Drivers of antibiotic use in Vietnam: implications for designing community interventions

Author:

McKinn ShannonORCID,Trinh Duy Hoang,Drabarek Dorothy,Trieu Thao Thu,Nguyen Phuong Thi Lan,Cao Thai Hung,Dang Anh Duc,Nguyen Thu Anh,Fox Greg J,Bernays SarahORCID

Abstract

IntroductionAntimicrobial resistance is a global challenge that threatens our ability to prevent and treat common infectious diseases. Vietnam is affected by high rates of antimicrobial resistant infections, driven by the overuse of antibiotics and the Vietnamese government has recognised antimicrobial resistance as a health security priority. This study aimed to understand how people in Vietnam use antibiotics in community settings, and the factors that impact their practices and decision-making regarding antibiotics.MethodsWe conducted 43 qualitative in-depth interviews with 50 community members in two urban and two rural sites in Vietnam. We conducted iterative, inductive thematic analysis alongside data collection through a process of systematic debriefings based on detailed interview summaries. Through this process, we developed a coding framework that was then applied to transcribed interview data.ResultsFrequent and indiscriminate use of antibiotics was driven by the powerful appeal that antibiotics held for many Vietnamese consumers. Consumers were discerning in making decisions in their purchase and use of antibiotics. Consumers’ decisions were affected by perceptions of what constitutes high-quality medicine (effective, strong, accessible and affordable); privileging symptom control over diagnosis; social constructions of antibiotics as a trusted remedy with embodied evidence of prior efficacy, which is reinforced by advice from trusted sources in their community; and varied, generally incomplete, understanding of the concept of antibiotic resistance and its implications for individuals and for public health.ConclusionAntibiotic use at the community and primary care level in Vietnam is driven by community members’ social and economic response to what constitutes effective healthcare, rather than biomedical logic. Community-based interventions to reduce unnecessary antibiotic use need to engage with the entangled socio-structural factors that ‘resist’ current public health efforts to ration antibiotic use, alongside biomedical drivers. This study has informed the design of a community-based trial to reduce unnecessary antibiotic use.

Funder

Department of Foreign Affairs and Trade, Australian Government

Publisher

BMJ

Subject

Public Health, Environmental and Occupational Health,Health Policy

Reference45 articles.

1. Interagency Coordination Group on Antimicrobial Resistance . No time to wait: securing the future from drug-resistant infections. Report to the Secretary-General of the United nations, 2019. Available: https://www.who.int/antimicrobial-resistance/interagency-coordination-group/IACG_final_report_EN.pdf

2. World Bank . Drug-Resistant infections: a threat to our economic future. Washington, DC World Bank; 2017. http://documents1.worldbank.org/curated/en/323311493396993758/pdf/final-report.pdf

3. The Review on Antimicrobial Resistance . Tackling drug-resistant infections globally: final report and recommendations. London The Review on Antimicrobial Resistance; 2016. https://amr-review.org/sites/default/files/160525_Final%20paper_with%20cover.pdf

4. World Health Organization . Global action plan on antimicrobial resistance. Geneva World Health Organization; 2015. https://apps.who.int/iris/bitstream/handle/10665/193736/9789241509763_eng.pdf

5. Tackling antimicrobial resistance in low-income and middle-income countries;Pokharel;BMJ Glob Health,2019

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3